RxDoctor Payments Data

Stacey Hayward

Psychiatric/Mental Health · Uniontown, PANPI 1508552787

Payments from drug & device makers

$2,519in general payments, 2019–2025

Across 143 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$464
  • Johnson & Johnson$443
  • Teva Pharmaceuticals USA, Inc.$411
  • Vanda Pharmaceuticals Inc.$348
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$252
  • Otsuka America Pharmaceutical, Inc.$208
  • plus $392 from 7 others

What the payments were for

  • Food & beverage$2,44397%
  • Education$763%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,519 in reported general payments places this provider in the 80th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$13,092
Medicare patients
52
Services billed
153

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate22$72,497
VraylarCariprazine Hcl38$53,471
Aripiprazole185$13,145
Lurasidone Hcl36$8,062
TrintellixVortioxetine Hydrobromide12$7,749
FetzimaLevomilnacipran Hcl11$5,291
Gabapentin202$2,906
Quetiapine Fumarate226$2,357
Trazodone Hcl221$2,300
Ziprasidone Hcl16$2,026
Perphenazine37$2,007
Venlafaxine Hcl ErVenlafaxine Hcl165$1,972
Hydroxyzine Hcl126$1,619
Lamotrigine189$1,545
Divalproex Sodium ErDivalproex Sodium36$1,273

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$443$72,49722 claims
AbbVieVraylar, Fetzima$464$58,76249 claims
Almatica Pharma LLCSertraline Hcl$14$1,010138 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Uniontown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →